ARDS trial is being done in rats not humans, TGA is for australia only not sure how they can impact the work of Eurofins Taiwan and the setting is a clinical trial?
Am I not understanding what the implications of this are or what. Maybe this could come into play when IHL moves to start a human trial using HCQ in Australia.
